Claus Egstrand

Claus Egstrand currently works at Enzymatica AB, as Chief Executive Officer from 2021, BBI Healthcare Ltd., as Director from 2018, Direct Healthcare Group Holdings Ltd., as Director from 2017, and Direct Healthcare Group Management Ltd., as Director from 2017.
Mr. Egstrand also formerly worked at Johnson & Johnson AB (Sweden), as Chief Executive Officer, Hologic, Inc., as Group President-International from 2014 to 2016, Merck & Co., Inc., as Head-European MSD Consumer Care, Pfizer Inc., as Senior Vice President-Consumer Healthcare from 2003 to 2006, Stryker Corp., as VP & General Manager-Medsurg Europe, Pharmacia AB, as Vice President & Head-Global Marketing, and Office Metro Ltd., as Chief Marketing Officer from 2006 to 2011.
Mr. Egstrand received his Masters Business Admin degree from the University of Copenhagen and undergraduate degree from Niels Brock Copenhagen Business College.